Cytology and mRNA expression analysis of fine needle aspirates of thyroid nodules in an East German region with borderline iodine deficiency

Hormone and Metabolic Research

Volumn 38, Issue 10, 2006, Pages 662-667

  Karger, S ^a   Engelhardt, C ^a   Eszlinger, M ^a   Tonjes A ^a   Herrmann, F ^b   Muller P ^b   Schmidt, Th ^c   Weiss, C L ^d   Dralle, H ^d   Lippitzsch, F ^b   Tannapfel, A ^a   Führer, Dagmar ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Bundeswehr Hospital Leipzig ^*

^c Universitary Hospital Leipzig   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Scintiscans; Tg mRNA; Thyroid lesion; actin

Indexed keywords

BETA ACTIN; MESSENGER RNA; THYROGLOBULIN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; FEMALE; GERMAN DEMOCRATIC REPUBLIC; HASHIMOTO DISEASE; HISTOPATHOLOGY; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID NODULE;

EID: 33751065888     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-954587     Document Type: Article

References (29)

1. Hampel R, Kulberg T, Klein K, Jerichow JU, Pichmann EG, Clausen V, Schmidt I. Goiter incidence in Germany is greater than previously suspected. Med Klin 1995; 90: 324-329
2. Volzke H, Ludemann J, Robinson DM, Spieker KW, Schwahn C, Kramer A, John U, Meng W. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003; 13: 803-810
3. Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, Schumm-Draeger PM. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 2004; 14: 926-932
4. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004; 89: 163-68
5. Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hufner M, Niederle B, Brabant G. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 2004; 112: 52-58
6. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003; 24: 102-32
7. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. (Review) Ann Intern Med 1993; 118: 282-289
8. Bennedbaek FN, Perrild H, Hegedus L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol 1999; 50: 357-363
9. Baloch ZW, Hendreen S, Gupta PK, LiVolsi VA, Mandel SJ, Weber R, Fraker D. Interinstitutional review of thyroid fine-needle aspirations: impact on clinical management of thyroid nodules. Diagn Cytopathol 2001; 25: 231-234
10. Baloch ZW, Sack MJ, Yu GH, LiVolsi VA, Gupta PK. Fine-needle aspiration of thyroid: an institutional experience. Thyroid 1998; 8: 565-569
11. Hamburger Ji. Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. J Clin Endocrinol Metab 1994; 79: 335-339
12. Oertel YC. Some thoughts about fine needle aspirations of thyroid nodules. Thyroid 2004; 14: 86-87
13. Oertel YC. A pathologist trying to help endocrinologists to interpret cytopathology reports from thyroid aspirates. J Clin Endocrinol Metab 2002; 87: 1459-461
14. Dietlein M, Dressler J, Eschner W, Leisner B, Reiners C, Schicha H. Procedure guideline for thyroid scintigraphy (version 2). Nuklearmedizin 2004; 42: 120-22
15. DeLellis R, Heitz P, Lloyd R, Eng C, WHO classification of tumors. Pathology and genetics of tumors of endocrine organs. IARC Press, 2004
16. Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD, Eng C. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 2005; 90: 2512-2521
17. Fagin JA. Mini review: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Mol Endocrinol 2002; 16: 903-911
18. Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N. Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma. Cancer Lett 2005; 219: 91-96
19. Brauer VF, Brauer WH, Fuhrer D, Paschke R. Iodine nutrition, nodular thyroid disease, and urinary iodine excretion in a German university study population. Thyroid 2005; 15: 364-370
20. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004; 351: 1764-771
21. Cibas ES, Ducatman BS. Cytology. Diagnostic principles and clinical correlates. 2nd Edition, Saunders, 2003
22. Führer D, Eszlinger M, Karger S, Krause K, Engelhardt C, Hasenclever D, Dralle H, Paschke R. Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours. Eur J Endocrinol 2005; 152: 785-790
23. Orell SR, Philipps J. The Thyroid Fine needle biobsy and cytological diagnosis of thyroid lesions. Monographys in Clinical Cytology Vo, 14 Karger
24. Hedayati N, McHenry CR. The clinical significance of an isofunctioning thyroid nodule. Am Surg 2003; 69: 311-316
25. Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 1996; 156: 2165-2172
26. de Vos tot Nederveen Chappel RJ, Bouvy ND, Bonjer HJ, van Muiswinkel JM, Chadha S. Fine needle aspiration cytology of thyroid nodules: how accurate is it and what are the causes of discrepant cases? Cytopathology 2001; 12: 399-405
27. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003; 88: 1433-441
28. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW, II, Tallini G, Kroll TG, Nikiforov YE. RAS point mutations and PAX8-PPAR rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 2003; 88: 2318-2326
29. Gardner HA, Ducatman BS, Wang HH. Predictive value of fine-needle aspiration of the thyroid in the classification of follicular lesions. Cancer 1993; 71: 2598-2603